Natixis Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.53M | Sell |
|
|||||
|
2025
Q2 | $6.46M | Buy |
|
|||||
|
2025
Q1 | $5.12M | Sell |
|
|||||
|
2024
Q4 | $11.1M | Buy |
|
|||||
|
2024
Q3 | $3.04M | Sell |
|
|||||
|
2024
Q2 | $3.27M | Buy |
|
|||||
|
2024
Q1 | $2.23M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2.74M | Sell |
|
|||||
|
2016
Q3 | $4M | Sell |
|
|||||
|
2016
Q2 | $5.01M | Sell |
|
|||||
|
2016
Q1 | $7.75M | Buy |
|
|||||
|
2015
Q4 | $9.29M | Sell |
|
|||||
|
2015
Q3 | $10.1M | Sell |
|
|||||
|
2015
Q2 | $15.2M | Sell |
|
|||||
|
2015
Q1 | $16.2M | Buy |
|
|||||
|
2014
Q4 | $13.3M | Buy |
|
|||||
|
2014
Q3 | $9.02M | Sell |
|
|||||
|
2014
Q2 | $11.1M | Buy |
|
|||||
|
2014
Q1 | $8.02M | Sell |
|
|||||
|
2013
Q4 | $6.62M | Sell |
|
|||||
|
2013
Q3 | $6.32M | Sell |
|
|||||
|
2013
Q2 | $6.92M | Buy |
|